India's Cipla says supply of COVID-19 drug remdesivir catching up with demand – Reuters

India’s Cipla says supply of COVID-19 drug remdesivir catching up with demand – Reuters

India’s Cipla (CIPL.NS) said on Saturday that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country.

Read More…

You May Also Like